Outcomes of conservative treatment for thoracic vascular graft infections
- PMID: 40439162
- PMCID: PMC12148214
- DOI: 10.1093/ejcts/ezaf171
Outcomes of conservative treatment for thoracic vascular graft infections
Abstract
Objectives: Thoracic vascular graft infections are devastating complications after aortic surgery, entailing high mortality. The gold standard treatment combines excisional surgery and antimicrobial therapy, but patients deemed inoperable might benefit from a conservative approach. Outcomes of patients treated only with antimicrobial agents without reoperative surgery are scanty. We aim to describe patients' characteristics and outcomes using an antibiotic-only strategy without thorough debridement.
Methods: Retrospectively collected data from a prospective cohort in a tertiary centre. Descriptive analysis for baseline characteristics and Kaplan-Meier estimates for survival were performed.
Results: From November 2012 to December 2022, 66 patients were identified with aortic root, ascending aortic and aortic arch graft infections. Of these, 44 received an antibiotic-only strategy or in combination with selective debridement after achieving multidisciplinary consensus. Median follow-up was 4.8 years [interquartile range (IQR) 1.7-6.1], and cumulative survival was 82.9% (CI 95%, 69.7-96.1). Streptococcus spp were the most common isolated microorganisms.
Conclusions: In selected cases, a conservative approach with antibiotics only or in combination with selective debridement showed acceptable results at follow-up, suggesting a valuable therapy option for this cohort of patients.
Keywords: Antimicrobial treatment; Endocarditis team; Thoracic vascular graft infection.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.
Figures
Similar articles
-
Resection and replacement of thoracic aortic graft infections.J Thorac Cardiovasc Surg. 2021 Jul;162(1):1-8. doi: 10.1016/j.jtcvs.2019.10.196. Epub 2019 Nov 27. J Thorac Cardiovasc Surg. 2021. PMID: 31926725
-
Homograft use in reoperative aortic root and proximal aortic surgery for endocarditis: A 12-year experience in high-risk patients.J Thorac Cardiovasc Surg. 2014 Sep;148(3):989-94. doi: 10.1016/j.jtcvs.2014.06.025. Epub 2014 Jun 14. J Thorac Cardiovasc Surg. 2014. PMID: 25043866
-
Thoracic aortic vascular graft infection: outcome after conservative treatment without graft removal.Eur J Cardiothorac Surg. 2022 Dec 2;63(1):ezac551. doi: 10.1093/ejcts/ezac551. Eur J Cardiothorac Surg. 2022. PMID: 36458920 Free PMC article.
-
Outcome after preservation of infected abdominal aortic endografts.J Endovasc Ther. 2014 Jun;21(3):448-55. doi: 10.1583/13-4575MR.1. J Endovasc Ther. 2014. PMID: 24915596 Review.
-
A systematic review of infected descending thoracic aortic grafts and endografts.J Vasc Surg. 2019 Jun;69(6):1941-1951.e1. doi: 10.1016/j.jvs.2018.10.108. Epub 2019 Jan 1. J Vasc Surg. 2019. PMID: 30606664
References
-
- Gott VL, Cameron DE, Alejo DE et al. Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann Thorac Surg 2002;73:438–43. - PubMed
-
- Ralph-Edwards A, David TE, Bos J. Infective endocarditis in patients who had replacement of the aortic root. Ann Thorac Surg 1994;58:429–32. - PubMed
-
- Takano T, Terasaki T, Wada Y, Seto T, Fukui D, Amano J. Treatment of prosthetic graft infection after thoracic aorta replacement. Ann Thorac Cardiovasc Surg 2014;20:304–9. - PubMed
-
- Oda T, Minatoya K, Kobayashi J et al. Prosthetic vascular graft infection through a median sternotomy: a multicentre review dagger. Interact CardioVasc Thorac Surg 2015;20:701–6; discussion 706. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous